{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T15:02:19Z","timestamp":1779980539244,"version":"3.53.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005771","name":"Dokuz Eyl\u00fcl \u00dcniversitesi","doi-asserted-by":"publisher","award":["TYL-2022-2619"],"award-info":[{"award-number":["TYL-2022-2619"]}],"id":[{"id":"10.13039\/501100005771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12042-z","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T12:17:47Z","timestamp":1779970667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of metformin-encapsulated poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles"],"prefix":"10.1007","volume":"53","author":[{"given":"Ezgi","family":"\u0130til","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eeniz \u0130nan\u00e7","family":"S\u00fcrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cevher Gundogdu","family":"Hizliates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclg\u00fcn","family":"Oktay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"issue":"9","key":"12042_CR1","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.3390\/ijms23094631","volume":"23","author":"D Grimm","year":"2022","unstructured":"Grimm D (2022) Recent advances in thyroid cancer research. Int J Mol Sci 23(9):4631","journal-title":"Int J Mol Sci"},{"issue":"14","key":"12042_CR2","doi-asserted-by":"publisher","first-page":"7707","DOI":"10.3390\/ijms22147707","volume":"22","author":"C Romano","year":"2021","unstructured":"Romano C, Martorana F, Pennisi MS, Stella S, Massimino M, Tirr\u00f2 E, Manzella L (2021) Opportunities and challenges of liquid biopsy in thyroid cancer. Int J Mol Sci 22(14):7707","journal-title":"Int J Mol Sci"},{"key":"12042_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.canlet.2020.08.021","volume":"496","author":"J Cao","year":"2021","unstructured":"Cao J, Zhang M, Zhang L, Lou J, Zhou F, Fang M (2021) Non-coding RNA in thyroid cancer-Functions and mechanisms. Cancer Lett 496:117\u2013126","journal-title":"Cancer Lett"},{"key":"12042_CR4","doi-asserted-by":"publisher","first-page":"04113","DOI":"10.7189\/jogh.15.04113","volume":"15","author":"Q Jin","year":"2025","unstructured":"Jin Q, Wu J, Huang C, Li J, Zhang Y, Ji Y, Huang Y (2025) Global landscape of early-onset thyroid cancer: current burden, temporal trend and future projections on the basis of GLOBOCAN 2022. J Global Health 15:04113","journal-title":"J Global Health"},{"issue":"7","key":"12042_CR5","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1158\/1055-9965.EPI-21-1440","volume":"31","author":"CM Kitahara","year":"2022","unstructured":"Kitahara CM, Schneider AB (2022) Epidemiology of thyroid cancer. Cancer Epidemiol Biomarkers Prev 31(7):1284\u20131297","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"12042_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41574-025-01168-y","volume":"22","author":"DW Chen","year":"2026","unstructured":"Chen DW, Haymart MR (2026) Unravelling the rise in thyroid cancer incidence and addressing overdiagnosis. Nat Reviews Endocrinol 22(1):10\u201320","journal-title":"Nat Reviews Endocrinol"},{"key":"12042_CR7","doi-asserted-by":"publisher","first-page":"1644270","DOI":"10.3389\/fendo.2025.1644270","volume":"16","author":"L Zhang","year":"2025","unstructured":"Zhang L, Jiang L, Xu R, Zhang X, Zhang B, Yue R (2025) Epidemiological study of thyroid cancer at global, regional, and national levels from 1990 to 2021: an analysis derived from the Global Burden of Disease Study 2021. Front Endocrinol 16:1644270","journal-title":"Front Endocrinol"},{"issue":"2","key":"12042_CR8","doi-asserted-by":"publisher","first-page":"R43","DOI":"10.1530\/JOE-17-0266","volume":"235","author":"MA Zaballos","year":"2017","unstructured":"Zaballos MA, Santisteban P (2017) Key signaling pathways in thyroid cancer. J Endocrinol 235(2):R43\u2013R61","journal-title":"J Endocrinol"},{"issue":"4","key":"12042_CR9","doi-asserted-by":"publisher","first-page":"284","DOI":"10.14740\/jocmr2480w","volume":"8","author":"S Jin","year":"2016","unstructured":"Jin S, Borkhuu O, Bao W, Yang YT (2016) Signaling pathways in thyroid cancer and their therapeutic implications. J Clin Med Res 8(4):284","journal-title":"J Clin Med Res"},{"key":"12042_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/bs.vh.2017.05.002","volume-title":"Signaling pathways in thyroid cancer. Vitamins and Hormones","author":"YT JinS, Yang","year":"2018","unstructured":"JinS,Yang YT, Bao W (2018) Signaling pathways in thyroid cancer. Vitamins and Hormones, vol 106. Academic, pp 501\u2013515. https:\/\/doi.org\/10.1016\/bs.vh.2017.05.002"},{"issue":"9","key":"12042_CR11","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1517\/14728222.2011.594044","volume":"15","author":"ECLD Souza","year":"2011","unstructured":"Souza ECLD, Ferreira ACF, Carvalho DPD (2011) The mTOR protein as a target in thyroid cancer. Expert Opin Ther Targets 15(9):1099\u20131112","journal-title":"Expert Opin Ther Targets"},{"issue":"3","key":"12042_CR12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nrc3431","volume":"13","author":"M Xing","year":"2013","unstructured":"Xing M (2013) Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer 13(3):184\u2013199","journal-title":"Nat Rev Cancer"},{"issue":"9356","key":"12042_CR13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0140-6736(03)12488-9","volume":"361","author":"SI Sherma","year":"2003","unstructured":"Sherma SI (2003) Thyroid carcinoma. Lancet 361(9356):501\u2013511","journal-title":"Lancet"},{"issue":"6","key":"12042_CR14","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.3390\/ijms18061292","volume":"18","author":"B Schmidbauer","year":"2017","unstructured":"Schmidbauer B, Menhart K, Hellwig D, Grosse J (2017) Differentiated thyroid cancer\u2014treatment: state of the art. Int J Mol Sci 18(6):1292","journal-title":"Int J Mol Sci"},{"issue":"8","key":"12042_CR15","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1210\/jc.2011-1109","volume":"96","author":"J Beckery","year":"2011","unstructured":"Beckery J (2011) Update on external beam radiation therapy in Thyroid cancer. J Clin Endocrinol Metab August 96(8):2289\u20132295","journal-title":"J Clin Endocrinol Metab August"},{"issue":"12","key":"12042_CR16","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1002\/ijc.25304","volume":"127","author":"D Liu","year":"2010","unstructured":"Liu D, Xing J, Trink B, Xing M (2010) BRAF mutation-selective inhibition of thyroid cancer cells by the novel MEK inhibitor RDEA119 and genetic\u2010potentiated synergism with the mTOR inhibitor temsirolimus. Int J Cancer 127(12):2965\u20132973","journal-title":"Int J Cancer"},{"key":"12042_CR17","doi-asserted-by":"crossref","unstructured":"Watkinson J (2008) Thyroid Cancer: A Comprehensive Guide to Clinical Management, 2nd edn","DOI":"10.1308\/rcsann.2008.90.4.360"},{"key":"12042_CR18","doi-asserted-by":"publisher","first-page":"102107","DOI":"10.1016\/j.jddst.2020.102107","volume":"61","author":"S Amirsaadat","year":"2021","unstructured":"Amirsaadat S, Jafari-Gharabaghlou D, Alijani S, Mousazadeh H, Dadashpour M, Zarghami N (2021) Metformin and Silibinin co-loaded PLGA-PEG nanoparticles for effective combination therapy against human breast cancer cells. J Drug Deliv Sci Technol 61:102107","journal-title":"J Drug Deliv Sci Technol"},{"issue":"8","key":"12042_CR19","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1210\/jc.2012-3799","volume":"98","author":"J Klubo-Gwiezdzinska","year":"2013","unstructured":"Klubo-Gwiezdzinska J, Costello Jr J, Patel A, Bauer A, Jensen K, Mete M, Vasko V (2013) Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer. J Clin Endocrinol Metabolism 98(8):3269\u20133279","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"1","key":"12042_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1530\/JME-16-0134","volume":"58","author":"CT Shen","year":"2017","unstructured":"Shen CT, Wei WJ, Qiu ZL, Song HJ, Zhang XY, Sun ZK, Luo QY (2017) Metformin reduces glycometabolism of papillary thyroid carcinoma in vitro and in vivo. J Mol Endocrinol 58(1):15\u201323","journal-title":"J Mol Endocrinol"},{"key":"12042_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","volume":"50","author":"GG Graham","year":"2011","unstructured":"Graham GG, Punt J, Arora M, Day RO, Doogue MP, Duong J, Williams KM (2011) Clinical pharmacokinetics of metformin. Clin Pharmacokinet 50:81\u201398","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"12042_CR22","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1016\/j.xphs.2017.04.078","volume":"106","author":"X Liang","year":"2017","unstructured":"Liang X, Giacomini KM (2017) Transporters involved in metformin pharmacokinetics and treatment response. J Pharm Sci 106(9):2245\u20132250","journal-title":"J Pharm Sci"},{"issue":"4","key":"12042_CR23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ejps.2004.03.016","volume":"22","author":"CL Cheng","year":"2004","unstructured":"Cheng CL, Lawrence XY, Lee HL, Yang CY, Lue CS, Chou CH (2004) Biowaiver extension potential to BCS Class III high solubility-low permeability drugs: bridging evidence for metformin immediate-release tablet. Eur J Pharm Sci 22(4):297\u2013304","journal-title":"Eur J Pharm Sci"},{"issue":"8","key":"12042_CR24","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.3109\/10717544.2015.1089957","volume":"23","author":"M Cetin","year":"2016","unstructured":"Cetin M, Sahin S (2016) Microparticulate and nanoparticulate drug delivery systems for metformin hydrochloride. Drug Delivery 23(8):2796\u20132805","journal-title":"Drug Delivery"},{"key":"12042_CR25","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s40820-020-00482-6","volume":"12","author":"W Mu","year":"2020","unstructured":"Mu W, Chu Q, Liu Y, Zhang N A review on nano-based drug delivery system for cancer chemoimmunotherapy. Nano-Micro Lett 12, 142 ((2020))","journal-title":"Nano-Micro Lett"},{"key":"12042_CR26","doi-asserted-by":"publisher","first-page":"5101","DOI":"10.1007\/s13277-014-1676-8","volume":"35","author":"M Aldea","year":"2014","unstructured":"Aldea M, Craciun L, Tomuleasa C, Berindan-Neagoe I, Kacso G, Florian IS, Crivii C (2014) Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery. Tumor Biology 35:5101\u20135110","journal-title":"Tumor Biology"},{"key":"12042_CR27","first-page":"10","volume":"1","author":"Y Dang","year":"2020","unstructured":"Dang Y, Guan J (2020) Nanoparticle-based drug delivery systems for cancer therapy. Smart Mater Med 1:10\u201319","journal-title":"Smart Mater Med"},{"key":"12042_CR28","doi-asserted-by":"crossref","unstructured":"Shukla SK, Kulkarni NS, Chan A, Parvathaneni V, Farrales P, Muth A, Gupta V (2020) Metformin-encapsulated liposome delivery system: An effective treatment approach against breast cancer. Pharmaceutics. 2019; 11 (11)","DOI":"10.3390\/pharmaceutics11110559"},{"issue":"2","key":"12042_CR29","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1208\/s12249-016-0505-3","volume":"18","author":"NC Ngwuluka","year":"2017","unstructured":"Ngwuluka NC, Kotak DJ, Devarajan PV (2017) Design and characterization of metformin-loaded solid lipid nanoparticles for colon cancer. AAPS PharmSciTech 18(2):358\u2013368","journal-title":"AAPS PharmSciTech"},{"issue":"18","key":"12042_CR30","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.3390\/polym16182606","volume":"16","author":"J Yang","year":"2024","unstructured":"Yang J, Zeng H, Luo Y, Chen Y, Wang M, Wu C, Hu P (2024) Recent applications of PLGA in drug delivery systems. Polymers 16(18):2606","journal-title":"Polymers"},{"key":"12042_CR31","doi-asserted-by":"crossref","unstructured":"Kenechukwu FC, Nnamani DO, Duhu JC, Nmesirionye BU, Momoh MA, Akpa PA, Attama AA (2022) Potential enhancement of metformin hydrochloride in solidified reverse micellar solution-based PEGylated lipid nanoparticles targeting therapeutic efficacy in diabetes treatment. Heliyon 8(3)","DOI":"10.1016\/j.heliyon.2022.e09099"},{"key":"12042_CR32","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ijbiomac.2021.12.097","volume":"201","author":"P Ghandforoushan","year":"2022","unstructured":"Ghandforoushan P, Hanaee J, Aghazadeh Z, Samiei M, Navali AM, Khatibi A, Davaran S (2022) Novel nanocomposite scaffold based on gelatin\/PLGA-PEG-PLGA hydrogels embedded with TGF-\u03b21 for chondrogenic differentiation of human dental pulp stem cells in vitro. Int J Biol Macromol 201:270\u2013287","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"12042_CR33","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1080\/21691401.2019.1573737","volume":"47","author":"L Faramarzi","year":"2019","unstructured":"Faramarzi L, Dadashpour M, Sadeghzadeh H, Mahdavi M, Zarghami N (2019) Enhanced anti-proliferative and pro-apoptotic effects of metformin encapsulated PLGA-PEG nanoparticles on SKOV3 human ovarian carcinoma cells. Artif cells Nanomed Biotechnol 47(1):737\u2013746","journal-title":"Artif cells Nanomed Biotechnol"},{"key":"12042_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1208\/s12249-013-0051-1","volume":"15","author":"E Khodaverdi","year":"2014","unstructured":"Khodaverdi E, Tekie FSM, Hadizadeh F, Esmaeel H, Mohajeri SA, Tabassi SAS, Zohuri G (2014) Hydrogels composed of cyclodextrin inclusion complexes with PLGA-PEG-PLGA triblock copolymers as drug delivery systems. AAPS PharmSciTech 15:177\u2013188","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"12042_CR35","first-page":"14","volume":"4","author":"MV Berridge","year":"1996","unstructured":"Berridge MV, Tan AS, McCoy KD, Wang RUI (1996) The biochemical and cellular basis of cell proliferation assays that use tetrazolium salts. Biochemica 4(1):14\u201319","journal-title":"Biochemica"},{"issue":"1\u20132","key":"12042_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1\u20132):55\u201363","journal-title":"J Immunol Methods"},{"issue":"6","key":"12042_CR37","first-page":"445","volume":"35","author":"GB K\u0131l\u0131\u00e7","year":"2010","unstructured":"K\u0131l\u0131\u00e7 GB, Karahan AG (2010) Fourier d\u00f6n\u00fc\u015f\u00fcml\u00fc k\u0131z\u0131l\u00f6tesi (FTIR) spektroskopisi ve laktik asit bakterilerinin tan\u0131s\u0131nda kullan\u0131lmas\u0131. G\u0131da 35(6):445\u2013452","journal-title":"G\u0131da"},{"key":"12042_CR38","doi-asserted-by":"publisher","unstructured":"Deb, PK, Kokaz SF, Abed SN, Paradkar A, Tekade RK (2019) Pharmaceutical and biomedical applications of polymers. In Basic fundamentals of drug delivery (pp. 203-267). Academic press. https:\/\/doi.org\/10.1016\/B978-0-12-817909-3.00006-6","DOI":"10.1016\/B978-0-12-817909-3.00006-6"},{"key":"12042_CR39","doi-asserted-by":"crossref","unstructured":"Pereira ED, Cerruti R, Fernandes E, Pe\u00f1a L, Saez, V., Pinto JC, \u2026 Souza FGD (2016). Influence of PLGA and PLGA-PEG on the dissolution profile of oxaliplatin. Pol\u00edmeros 26(2):137\u2013143","DOI":"10.1590\/0104-1428.2323"},{"issue":"2","key":"12042_CR40","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","volume":"161","author":"F Danhier","year":"2012","unstructured":"Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Pr\u00e9at V (2012) PLGA-based nanoparticles: an overview of biomedical applications. J Controlled Release 161(2):505\u2013522","journal-title":"J Controlled Release"},{"key":"12042_CR41","doi-asserted-by":"publisher","first-page":"111300","DOI":"10.1016\/j.colsurfb.2020.111300","volume":"196","author":"A Otte","year":"2020","unstructured":"Otte A, Sharifi F, Park K (2020) Interfacial tension effects on the properties of PLGA microparticles. Colloids Surf B 196:111300","journal-title":"Colloids Surf B"},{"key":"12042_CR42","doi-asserted-by":"publisher","first-page":"341848","DOI":"10.1155\/2015\/341848","volume":"20151","author":"S Derman","year":"2015","unstructured":"Derman S (2015) Caffeic acid phenethyl ester loaded PLGA nanoparticles: effect of various process parameters on reaction yield, encapsulation efficiency, and particle size. J Nanomaterials 20151:341848\u2013342023","journal-title":"J Nanomaterials"},{"issue":"4","key":"12042_CR43","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1007\/s11033-022-08171-w","volume":"50","author":"D Jafari-Gharabaghlou","year":"2023","unstructured":"Jafari-Gharabaghlou D, Dadashpour M, Khanghah OJ, Salmani-Javan E, Zarghami N (2023) Potentiation of Folate-Functionalized PLGA-PEG nanoparticles loaded with metformin for the treatment of breast Cancer: possible clinical application. Mol Biol Rep 50(4):3023\u20133033","journal-title":"Mol Biol Rep"},{"issue":"3","key":"12042_CR44","doi-asserted-by":"publisher","first-page":"382","DOI":"10.15171\/apb.2019.045","volume":"9","author":"TNS Sulaiman","year":"2019","unstructured":"Sulaiman TNS, Larasati D, Nugroho AK, Choiri S (2019) Assessment of the Effect of PLGA Co-polymers and PEG on the Formation and Characteristics of PLGA-PEG-PLGA Co-block Polymer Using Statistical Approach. Adv Pharm Bull 9(3):382","journal-title":"Adv Pharm Bull"},{"key":"12042_CR45","doi-asserted-by":"crossref","unstructured":"Danaei MRMM, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, \u2026 Mozafari MR (2018). Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics 10(2):57","DOI":"10.3390\/pharmaceutics10020057"},{"key":"12042_CR46","doi-asserted-by":"publisher","first-page":"712367","DOI":"10.3389\/fmed.2021.712367","volume":"8","author":"G Zambito","year":"2021","unstructured":"Zambito G, Deng S, Haeck J, Gaspar N, Himmelreich U, Censi R, Mezzanotte L (2021) Fluorinated PLGA-PEG-mannose nanoparticles for tumor-associated macrophage detection by optical imaging and MRI. Front Med 8:712367","journal-title":"Front Med"},{"issue":"14","key":"12042_CR47","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.3390\/app10144891","volume":"10","author":"K Devasvaran","year":"2020","unstructured":"Devasvaran K, Jairaman S, Yahaya NA, Jaganath IBS, Khung YL, Lim V, Ngalim SH (2020) PEG-b-PLGA nanoparticles loaded with Geraniin from Phyllanthus watsonii extract as a phytochemical delivery model. Appl Sci 10(14):4891","journal-title":"Appl Sci"},{"issue":"11","key":"12042_CR48","doi-asserted-by":"publisher","first-page":"e27535","DOI":"10.1371\/journal.pone.0027535","volume":"6","author":"C Dieterich","year":"2011","unstructured":"DieterichC, Relman DA (2011) Modulation of the host interferon response and ISGylation pathway by B. pertussis filamentous hemagglutinin. PLoS ONE 6(11):e27535. https:\/\/doi.org\/10.1371\/journal.pone.0027535","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"12042_CR49","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.pain.2005.08.027","volume":"120","author":"U Bingel","year":"2006","unstructured":"Bingel U, Lorenz J, Schoell E, Weiller C, B\u00fcchel C (2006) Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain 120(1\u20132):8\u201315","journal-title":"Pain"},{"key":"12042_CR50","doi-asserted-by":"crossref","unstructured":"Shao XR, Wei XQ, Song X, Hao LY, Cai XX, Zhang ZR, \u2026 Lin YF (2015). Independent effect of polymeric nanoparticle zeta potential\/surface charge, on their cytotoxicity and affinity to cells. Cell proliferation 48(4):465\u2013474","DOI":"10.1111\/cpr.12192"},{"key":"12042_CR51","doi-asserted-by":"publisher","first-page":"102293","DOI":"10.1016\/j.jddst.2020.102293","volume":"61","author":"H Liu","year":"2021","unstructured":"Liu H, Gong L, Lu S, Wang H, Fan W, Yang C (2021) Three core-shell polymersomes for targeted doxorubicin delivery: Sustained and acidic release. J Drug Deliv Sci Technol 61:102293","journal-title":"J Drug Deliv Sci Technol"},{"issue":"2","key":"12042_CR52","doi-asserted-by":"publisher","first-page":"519","DOI":"10.31557\/APJCP.2022.23.2.519","volume":"23","author":"ES Javan","year":"2022","unstructured":"Javan ES, Lotfi F, Jafari-Gharabaghlou D, Mousazadeh H, Dadashpour M, Zarghami N (2022) Development of a magnetic nanostructure for co-delivery of metformin and silibinin on growth of lung cancer cells: possible action through leptin gene and its receptor regulation. Asian Pac J Cancer Prevention: APJCP 23(2):519","journal-title":"Asian Pac J Cancer Prevention: APJCP"},{"issue":"4","key":"12042_CR53","doi-asserted-by":"publisher","first-page":"E510","DOI":"10.1210\/jc.2011-1754","volume":"97","author":"G Chen","year":"2012","unstructured":"Chen G, Xu S, Renko K, Derwahl M (2012) Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents. J Clin Endocrinol Metabolism 97(4):E510\u2013E520","journal-title":"J Clin Endocrinol Metabolism"},{"key":"12042_CR54","unstructured":"Koopaei MN, Khoshayand MR, Mostafavi, SH, Amini M, Khorramizadeh MR, Tehrani MJ, \u2026 Dinarvand R (2014). Docetaxel loaded PEG-PLGA nanoparticles:optimized drug loading, in-vitro cytotoxicity and in-vivo antitumor effect. Iranian journal of pharmaceutical research: IJPR 13(3):819"},{"issue":"5","key":"12042_CR55","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1080\/21691401.2017.1347879","volume":"46","author":"R Farajzadeh","year":"2018","unstructured":"Farajzadeh R, Pilehvar-Soltanahmadi Y, Dadashpour M, Javidfar S, Lotfi-Attari J, Sadeghzadeh H, Zarghami N (2018) Nano-encapsulated metformin-curcumin in PLGA\/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells. Artif cells Nanomed Biotechnol 46(5):917\u2013925","journal-title":"Artif cells Nanomed Biotechnol"},{"key":"12042_CR56","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.3389\/fphar.2019.01676","volume":"10","author":"S Li","year":"2020","unstructured":"Li S, Dong S, Xu W, Jiang Y, Li Z (2020) Polymer nanoformulation of sorafenib and all-trans retinoic acid for synergistic inhibition of thyroid cancer. Front Pharmacol 10:1676","journal-title":"Front Pharmacol"},{"issue":"1","key":"12042_CR57","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1080\/10717544.2020.1775723","volume":"27","author":"T Yu","year":"2020","unstructured":"Yu T, Tong L, Ao Y, Zhang G, Liu Y, Zhang H (2020) NIR triggered PLGA coated Au-TiO2 core loaded CPT-11 nanoparticles for human papillary thyroid carcinoma therapy. Drug Delivery 27(1):855\u2013863","journal-title":"Drug Delivery"},{"key":"12042_CR58","doi-asserted-by":"crossref","unstructured":"Chandel, NS, Avizonis D, Reczek CR, Weinberg SE, Menz S, Neuhaus R, \u2026 Pollak M (2016). Are metformin doses used in murine cancer models clinically relevant? Cell metabolism 23(4):569\u2013570","DOI":"10.1016\/j.cmet.2016.03.010"},{"issue":"2","key":"12042_CR59","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cmet.2015.01.003","volume":"21","author":"L He","year":"2015","unstructured":"He L, Wondisford FE (2015) Metformin action: concentrations matter. Cell Metabol 21(2):159\u2013162","journal-title":"Cell Metabol"},{"issue":"3","key":"12042_CR60","first-page":"384","volume":"4","author":"SI Surer","year":"2020","unstructured":"Surer SI, Toksoz F, Bayrak S, Meco HE, Sever T, Basbinar Y, Olgun HN (2020) Repositioning of Metformin: Anticancer Agent for Hypoxic Neuroblastoma Cells. J Basic Clin Health Sci 4(3):384\u2013390","journal-title":"J Basic Clin Health Sci"},{"key":"12042_CR61","doi-asserted-by":"crossref","unstructured":"Klubo-Gwiezdzinska J, Costello Jr, J, Patel, A, Bauer A, Jensen K, Mete M, \u2026 Vasko V (2013). Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer. The Journal of Clinical Endocrinology & Metabolism 98(8):3269\u20133279","DOI":"10.1210\/jc.2012-3799"},{"issue":"9","key":"12042_CR62","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","volume":"60","author":"G Rena","year":"2017","unstructured":"Rena G, Hardie DG, Pearson ER (2017) The mechanisms of action of metformin. Diabetologia 60(9):1577\u20131585","journal-title":"Diabetologia"},{"issue":"4","key":"12042_CR63","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1038\/ijo.2008.116","volume":"32","author":"DG Hardie","year":"2008","unstructured":"Hardie DG (2008) AMPK: a key regulator of energy balance in the single cell and the whole organism. Int J Obes 32(4):S7\u2013S12","journal-title":"Int J Obes"},{"issue":"4","key":"12042_CR64","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3390\/biom12040574","volume":"12","author":"M Garc\u00eda-S\u00e1enz","year":"2022","unstructured":"Garc\u00eda-S\u00e1enz M, Lobaton-Ginsberg M, Ferreira-Hermosillo A (2022) Metformin in differentiated thyroid cancer: molecular pathways and its clinical implications. Biomolecules 12(4):574","journal-title":"Biomolecules"},{"key":"12042_CR65","doi-asserted-by":"crossref","unstructured":"Bikas A, Jensen K, Patel A, Costello J, McDaniel D, Klubo-Gwiezdzinska J, \u2026 Vasko V (2015). Glucose-deprivation increases thyroid cancer cells sensitivity to metformin. Endocrine-related cancer 22(6):919\u2013932","DOI":"10.1530\/ERC-15-0402"},{"issue":"3","key":"12042_CR66","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1530\/ERC-12-0046","volume":"19","author":"J Klubo-Gwiezdzinska","year":"2012","unstructured":"Klubo-Gwiezdzinska J, Jensen K, Costello J, Patel A, Hoperia V, Bauer A, Vasko V (2012) Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells. Endocrine-related Cancer 19(3):447\u2013456","journal-title":"Endocrine-related Cancer"},{"issue":"7","key":"12042_CR67","doi-asserted-by":"publisher","first-page":"E1368","DOI":"10.1210\/jc.2014-1171","volume":"99","author":"TS Plantinga","year":"2014","unstructured":"Plantinga TS, Heinhuis B, Gerrits D, Netea MG, Joosten LA, Hermus AR, Netea-Maier RT (2014) mTOR Inhibition promotes TTF1-dependent redifferentiation and restores iodine uptake in thyroid carcinoma cell lines. J Clin Endocrinol Metabolism 99(7):E1368\u2013E1375","journal-title":"J Clin Endocrinol Metabolism"},{"key":"12042_CR68","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3389\/fendo.2012.00133","volume":"3","author":"M Saiselet","year":"2012","unstructured":"Saiselet M, Floor S, Tarabichi M, Dom G, H\u00e9brant A, van Staveren WC, Maenhaut C (2012) Thyroid cancer cell lines: an overview. Front Endocrinol 3:133","journal-title":"Front Endocrinol"},{"key":"12042_CR69","doi-asserted-by":"crossref","unstructured":"Wu Y, Gao WN, Xue YN, Zhang LC, Zhang JJ, Lu SY, \u2026 Sun LK (2018). SIRT3 aggravates metformin-induced energy stress and apoptosis in ovarian cancer cells. Experimental Cell Research 367(2):137\u2013149","DOI":"10.1016\/j.yexcr.2018.03.030"},{"issue":"5","key":"12042_CR70","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.cmet.2010.03.014","volume":"11","author":"A Kalender","year":"2010","unstructured":"Kalender A, Selvaraj A, Kim SY, Gulati P, Br\u00fbl\u00e9 S, Viollet B, Thomas G (2010) Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. Cell Metabol 11(5):390\u2013401","journal-title":"Cell Metabol"},{"issue":"5","key":"12042_CR71","doi-asserted-by":"publisher","first-page":"E748","DOI":"10.1210\/jc.2014-1777","volume":"100","author":"RL Plews","year":"2015","unstructured":"Plews RL, Mohd Yusof A, Wang C, Saji M, Zhang X, Chen CS, Phay JE (2015) A novel dual AMPK activator\/mTOR inhibitor inhibits thyroid cancer cell growth. J Clin Endocrinol Metabolism 100(5):E748\u2013E756","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"2","key":"12042_CR72","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s12020-017-1503-2","volume":"59","author":"SH Kim","year":"2018","unstructured":"Kim SH, Kang JG, Kim CS, Ihm SH, Choi MG, Yoo HJ, Lee SJ (2018) Synergistic cytotoxicity of the dipeptidyl peptidase-IV inhibitor gemigliptin with metformin in thyroid carcinoma cells. Endocrine 59(2):383\u2013394","journal-title":"Endocrine"},{"issue":"6","key":"12042_CR73","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.7150\/jca.16584","volume":"8","author":"S Kheder","year":"2017","unstructured":"Kheder S, Sisley K, Hadad S, Balasubramanian SP (2017) Effects of prolonged exposure to low dose metformin in thyroid cancer cell lines. J Cancer 8(6):1053\u20131061 Go to original source. Go to PubMed","journal-title":"J Cancer"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12042-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12042-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12042-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T14:04:00Z","timestamp":1779977040000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12042-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12042"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12042-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"16 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"852"}}